Trailing-twelve-month (TTM) revenue is $153.60 Billion with a year-over-year growth of +15.77%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $34,505,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-29 |
| Q4 FY2025Period ended 2025-12-31 | $34,015,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-20 |
| Q1 FY2026Period ended 2026-03-31 | $34,076,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-29 |
| Q2 FY2026Period ended 2026-06-30 | $51,004,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $153,600,000,000 |
Current P/S: $104,555,834,516 market capitalization ÷ $153,600,000,000 TTM revenue = 0.68x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $51.00B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:03.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Chemicals Segment | N/A | N/A | N/A | N/A | $863M | N/A |
| Consolidation, Eliminations | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| GERMANY | $3.0B | $4.3B | $6.4B | $5.5B | $5.3B | $5.0B |
| Other Geographical Areas | $5.4B | $8.1B | $9.9B | $8.4B |
$153.60B
$153.60 Billion
+15.77%
vs. $132.68B a year ago (TTM)
+13.56%
5 Year compound annual growth rate
1 Year
+15.77%
3 Year
+0.99%
5 Year
+13.56%
10 Year
+5.86%
15 Year
(0.70%)
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $132.19B | ($10.93B) | (7.64%) |
| 2024 | $143.12B | ($4.14B) | (2.81%) |
| 2023 | $147.26B | ($22.86B) | (13.44%) |
| 2022 | $170.12B | +$58.17B | +51.97% |
| 2021 | $111.94B | +$48.25B | +75.76% |
| 2020 |
TTM Growth
+15.77%
3-Year CAGR
+0.99%
5-Year CAGR
+13.56%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:03.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| -$58.7B |
| $55.8B |
| Corporate and Other | N/A | N/A | N/A | N/A | $236M | N/A |
|---|
| Crude Oil | $9.1B | $12.8B | $20.6B | $20.8B | N/A | $15.2B |
|---|
| Marketing And Specialties Segment | -$1.3B | $2.0B | N/A | N/A | $92.8B | N/A |
|---|
| Midstream Segment | N/A | N/A | $2.9B | -$2.8B | $19.7B | N/A |
|---|
| Natural Gas Liquids | $4.1B | $9.1B | $16.2B | $14.5B | N/A | $17.1B |
|---|
| Other Product Line | $1.2B | $581M | $1.4B | $3.5B | N/A | $2.8B |
|---|
| Refined products | $49.8B | $89.0B | $131.8B | $108.6B | N/A | N/A |
|---|
| Refining Segment | N/A | N/A | N/A | N/A | $85.0B | N/A |
|---|
| Renewable Fuels | N/A | N/A | N/A | N/A | $5.6B | N/A |
|---|
| $11.6B |
| $9.9B |
| UNITED KINGDOM | $7.0B | $11.1B | $16.7B | $14.6B | $12.7B | $13.2B |
|---|
| UNITED STATES | $48.7B | $88.0B | $137.0B | $118.8B | $113.6B | $104.3B |
|---|
| $63.69B |
| ($43.75B) |
| (40.72%) |
| 2019 | $107.44B | ($3.83B) | (3.44%) |
| 2018 | $111.27B | +$21.72B | +24.26% |
| 2017 | $89.55B | +$18.20B | +25.51% |
| 2016 | $71.35B | ($13.68B) | (16.09%) |
